Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma.

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Miyake and Masakatsu Yamashita has discovered that Bach2, a protein essential for regulating T cells function, plays a ...

Like other types of cancer, carcinomas are abnormal cells that divide without control. They are able to spread to other parts of the body, but don't always. "Carcinoma in situ" stays in the cells ...

These receptors allow T cells to sense and respond to diverse types of infection. Despite mass vaccination against Bordetella Pertussis (BP), whooping cough remains a serious and prevalent disease ...

The immune system is the body’s tool for preventing or limiting infection. Its complex network of cells, organs, proteins, and tissues enables the immune system to defend the body from pathogens.

A type of T cell that helps B cells, the T-follicular helper cells, also disappeared with CAR T therapy, but were “perfectly fine” with rituximab, he added. “The depth of this depletion is ...